Invesco Ltd. Boosts Stock Position in The Chemours Company (NYSE:CC)

Invesco Ltd. grew its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 141.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,020,001 shares of the specialty chemicals company's stock after buying an additional 597,638 shares during the period. Invesco Ltd. owned 0.68% of Chemours worth $17,238,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of CC. Strategic Financial Concepts LLC purchased a new stake in Chemours during the 4th quarter valued at $357,000. Entropy Technologies LP bought a new stake in shares of Chemours during the 4th quarter valued at about $266,000. Sei Investments Co. increased its position in shares of Chemours by 779.5% during the 4th quarter. Sei Investments Co. now owns 174,555 shares of the specialty chemicals company's stock valued at $2,950,000 after purchasing an additional 154,709 shares during the last quarter. Twelve Points Wealth Management LLC raised its holdings in Chemours by 42.8% in the 4th quarter. Twelve Points Wealth Management LLC now owns 78,325 shares of the specialty chemicals company's stock worth $1,324,000 after purchasing an additional 23,490 shares during the period. Finally, Geode Capital Management LLC raised its stake in shares of Chemours by 1.2% in the third quarter. Geode Capital Management LLC now owns 2,491,748 shares of the specialty chemicals company's stock worth $50,646,000 after buying an additional 28,803 shares during the period. Hedge funds and other institutional investors own 76.26% of the company's stock.

Analyst Ratings Changes

Several equities analysts have weighed in on CC shares. Barclays lowered their price target on shares of Chemours from $19.00 to $16.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 1st. Mizuho set a $15.00 price objective on shares of Chemours in a research report on Tuesday, April 15th. BMO Capital Markets decreased their target price on shares of Chemours from $34.00 to $27.00 and set an "outperform" rating on the stock in a research report on Wednesday, February 19th. Morgan Stanley dropped their price target on Chemours from $25.00 to $22.00 and set an "equal weight" rating for the company in a research report on Monday, January 13th. Finally, The Goldman Sachs Group decreased their price objective on Chemours from $24.00 to $21.00 and set a "neutral" rating on the stock in a research report on Tuesday, January 7th. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $21.56.

Chemours Trading Up 4.6 %

CC traded up $0.55 during trading hours on Thursday, reaching $12.38. 1,313,128 shares of the company's stock traded hands, compared to its average volume of 1,855,248. The company has a quick ratio of 0.92, a current ratio of 1.68 and a debt-to-equity ratio of 6.70. The firm has a 50-day moving average price of $13.49 and a 200 day moving average price of $17.17. The Chemours Company has a 52-week low of $9.33 and a 52-week high of $29.21. The firm has a market capitalization of $1.85 billion, a PE ratio of 21.70 and a beta of 1.84.

Chemours (NYSE:CC - Get Free Report) last issued its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, topping analysts' consensus estimates of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The business had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.37 billion. As a group, sell-side analysts predict that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 8.08%. The ex-dividend date was Friday, February 28th. Chemours's dividend payout ratio (DPR) is 175.44%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.